Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $1.24 Million - $1.64 Million
-8,200 Reduced 56.94%
6,200 $1.22 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $1.96 Million - $2.26 Million
11,700 Added 433.33%
14,400 $2.51 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $1.32 Million - $1.53 Million
-8,200 Reduced 75.23%
2,700 $464,000
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $989,263 - $1.19 Million
6,800 Added 165.85%
10,900 $1.81 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $537,674 - $645,627
4,100 New
4,100 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.